COMMUNIQUÉS West-GlobeNewswire

Ritter Pharmaceuticals To Present at Noble Capital Markets’ Fifteenth Annual Investor/Equity Conference on January 28, 2019
23/01/2019
LOS ANGELES, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]
Imagin Medical to Present at Noble Capital Markets’ 15th Annual Investor Conference
23/01/2019
VANCOUVER, British Columbia and BOSTON, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in the [...]
MyoKardia Appoints William Fairey as Chief Commercial Officer
23/01/2019
SOUTH SAN FRANCISCO, Calif., Jan. 23, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
Bermekimab Successfully Treats Hidradenitis Suppurativa, Including Significant Reduction in Pain
23/01/2019
Bermekimab Treats HS Patients Even After Failure with Leading Biological Therapy AUSTIN, Texas, Jan. 23, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today the successful outcome of its multicenter, open [...]
Attune Pharmaceuticals Announces $23M Series B Financing to Advance ATN-249 for the Treatment of HAE
23/01/2019
NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Attune Pharmaceuticals, Inc., a biotechnology company focused on the discovery and development of novel, orally-administered, small molecule therapeutics for the treatment of [...]
Biocartis Group NV: BIOCARTIS LAUNCHES EQUITY PLACEMENT
23/01/2019
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW [...]
Foamix Announces Appointment of Sharon Barbari to Board of Directors
23/01/2019
REHOVOT, Israel, and BRIDGEWATER, N.J., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing [...]
IntelGenx Provides Update on Phase 2a Montelukast VersaFilm™ Clinical Trial
23/01/2019
Eight Alzheimer’s Disease Patients Randomized to Date with Two Additional Sites Expected SAINT LAURENT, Quebec, Jan. 23, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral [...]
Cabaletta Bio Appoints Anup Marda as Chief Financial Officer
23/01/2019
Mr. Marda joins Cabaletta with 17 years of financial leadership experience RADNOR, Pa., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc., a biotechnology company focused on the discovery and development of cellular [...]
Telix Pharmaceuticals Launches illumet™ Microsite (Kit for the Preparation of 68Ga-PSMA)
23/01/2019
MELBOURNE, Australia and INDIANAPOLIS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic and [...]
BioCorRx Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market
23/01/2019
ANAHEIM, CA, Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX; BICXD) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, [...]
InspireMD Announces Two Successful Live Clinical Case Transmissions Featuring CGuard™ EPS at the Leipzig Interventional Course (LINC) 2019
23/01/2019
Cases demonstrate ease-of-use of CGuard™ EPS in two challenging clinical situations physicians face when treating carotid artery disease TEL AVIV, Israel, Jan. 23, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American [...]
ProMIS Neurosciences Completes Private Placement of Units
23/01/2019
NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 23, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (“ ProMIS ” or the “ Company ”) (TSX: PMN); (OTCQB:ARFXF) is [...]
T2 Biosystems to Participate in Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
23/01/2019
Company to highlight groundbreaking diagnostic innovations impacting antimicrobial resistance and sepsis management LEXINGTON, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the [...]
Sharps Compliance Reports Fiscal 2019 Second Quarter Results
23/01/2019
Second quarter 2019 revenue increased to $12.4 million with gross margin of 32%, net income of $0.8 million and $0.05 earnings per share Mailback business increased 20% for the quarter reflecting strong flu business [...]
Publishing of Orion Corporation's Financial Statement Release for 2018 on 6 February 2019
23/01/2019
ORION CORPORATION PRESS RELEASE 23 JANUARY 2019 at 13.30 EET Publishing of Orion Corporation's Financial Statement Release for 2018 on 6 February 2019 Orion will publish its Financial Statement Release for 2018 on [...]
New Study Shows Supplementation with Nicotinamide Riboside (NR) During Breastfeeding Yields Measurable, Lasting Benefits to Mothers and Offspring in Animal Model
23/01/2019
Landmark preclinical lactation study of unique form of vitamin B3 (nicotinamide riboside) showing remarkable results in rodents published in Cell Reports LOS ANGELES, Jan. 23, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. ( [...]
Athersys Announces Positive Results From Its Exploratory Clinical Study of MultiStem® Cell Therapy for Treatment of Acute Respiratory Distress Syndrome (ARDS)
23/01/2019
Results Confirm Safety Profile and Demonstrate Meaningful Potential Benefits in Mortality, Ventilator-free Days and ICU-free Days CLEVELAND, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced [...]
New REDUCE-IT™ Trial Data Showing the Total Reduction in Ischemic Events Accepted for Presentation at the American College of Cardiology’s 68th Annual Scientific Session
23/01/2019
BEDMINSTER, N.J., and DUBLIN, Ireland, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, announced that new data showing the [...]

Pages